Potential for the use of the solitaire stent for recanalization of middle cerebral artery occlusion without a susceptibility vessel sign

American Journal of Neuroradiology

Volumn 35, Issue 1, 2014, Pages 149-155

  Bae, Y J ^a   Jung, Cheolkyu ^a   Kim, J H ^a   Choi, B S ^a   Kim, E ^a   Han, M K ^a   Bae, H J ^a   Han, M H ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; GADOLINIUM; TIROFIBAN; UROKINASE;

ADULT; AGED; ARTERIAL OCCLUSIVE LESION SCORE; ARTERY REOCCLUSION; ARTICLE; BALLOON CATHETER; BRAIN ISCHEMIA; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; ENDOVASCULAR SURGERY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGING SYSTEM; INTRACRANIAL STENT; MALE; MECHANICAL THROMBECTOMY; MICROCATHETER; MIDDLE AGED; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RECANALIZATION; SAFETY; SCORING SYSTEM; SOLITAIRE AB STENT; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS; CEREBRAL REVASCULARIZATION; FEASIBILITY STUDIES; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PROGNOSIS; REOPERATION; STENTS; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84892765770     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3562     Document Type: Article

References (37)

1. Henkes H, Flesser A, Brew S, et al. A novel microcatheter-delivered, highly-flexible and fully-retrievable stent, specifically designed for intracranial use. Interv Neuroradiol 2003;9:391-93
2. Lubicz B, Collignon L, Raphaeli G, et al. Solitaire stent for endovascular treatment of intracranial aneurysms: immediate and midterm results in 15 patients with 17 aneurysms. J Neuroradiol 2010;37:83-88
3. Klisch J, Eger C, Sychra V, et al. Stent-assisted coil embolization of posterior circulation aneurysms using Solitaire ab: preliminary experience. Neurosurgery 2009;65:258
4. Castaño C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836-40
5. Stampfl S, Hartmann M, Ringleb PA, et al. Stent placement for flow restoration in acute ischemic stroke: a single-center experience with the Solitaire stent system. AJNR Am J Neuroradiol 2011;32:1245-48
6. Brekenfeld C, Schroth G, Mordasini P, et al. Impact of retrievable stents on acute ischemic stroke treatment. AJNR Am J Neuroradiol 2011;32:1269-73
7. Nayak S, Ladurner G, Killer M. Treatment of acute middle cerebral artery occlusion with a Solitaire AB stent: preliminary experience. Br J Radiol 2010;83:1017-22
8. Saver JL, Jahan R, Levy EI, et al, for the SWIFT Trialists. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-49
9. Rovira A, Orellana P, Alvarez-Sabín J, et al. Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004;232:466-73
10. Flacke S, Urbach H, Keller E, et al. Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology 2000;215:476-82
11. Liebeskind DS, Sanossian N, Yong WH, et al. CT and MRIearly vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237-43
12. Cho KH, Kim JS, Kwon SU, et al. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379-83
13. Barber PA, Hill MD, Eliaziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005;76:1528-33
14. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-38
15. Fiehler J, Knudsen K, Thomalla G, et al. Vascular occlusion sites determine differences in lesion growth from early apparent diffusion coefficient lesion to final infarct. AJNR Am J Neuroradiol 2005;26:1056-61
16. Khatri P, Neff J, Broderick JP, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-03
17. Wong K, Lam WWM, Liang E, et al. Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke 1996;27:1084-87
18. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82
19. Larrue V, von Kummer R, Müller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-41
20. Miteff F, Faulder K, Goh A, et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral artery occlusion. AJNR Am J Neuroradiol 2011;32:1078-81
21. Costalat V, Machi P, Lobotesis K, et al. Rescue, combined, and standalone thrombectomy in the management of large vessel occlusion stroke using the Solitaire device: a prospective 50-patient singlecenter study. Stroke 2011;42:1929-35
22. Ueda T, Sakaki S, Nochide I, et al. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568-74
23. Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781-85
24. Suh DC, Kim EH. The therapeutic time window related to the presenting symptom pattern, that is, stable versus unstable patients, can affect the adverse event rate of intracranial stenting. Stroke 2009;40:e588-89, author reply e590
25. Dorn F, Prothmann S, Wunderlich S, et al. Stent angioplasty of intracranial stenosis: single center experience of 54 cases. Clin Neuroradiol 2012;22:149-56
26. Abou-Chebl A, Steinmetz H. Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz, et al in the New England Journal of Medicine. Stroke 2012;43:616-20
27. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003
28. Ogata J, Masuda J, Yutani C, et al. Mechanisms of cerebral artery thrombosis: a histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry 1994;57:17-21
29. Komotar RJ, Mocco J, Wilson DA, et al. The natural history of intracranial carotid artery atherosclerosis. Neurosurg Focus 2005;18:e5
30. Rauch U, Osende JI, Fuster V, et al. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001;134:224
31. Heo JH, Lee KY, Kim SH, et al. Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study. Neurology 2003;60:1684-87
32. Mangiafico S, Cellerini M, Nencini P, et al. Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 2005;26:2595-601
33. Torgano G, Zecca B, Monzani V, et al. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. Cerebrovasc Dis 2010;29:275-81
34. Kwon JH, Shin SH, Weon YC, et al. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients. Neuroradiology 2011;53:779-85
35. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99
36. Johnston DC, Hill MD. The patient with transient cerebral ischemia: a golden opportunity for stroke prevention. CMAJ 2004;170:1134-37
37. Jakubowska MM, Michels P, Müller-Jensen A, et al. Endovascular treatment in proximal and intracranial carotid occlusion 9 hours after symptom onset. Neuroradiology 2008;50:599-604